USPSTF: Evidence Lacking for Open-Angle Glaucoma Screening
Current evidence is insufficient for assessing the balance of benefits and harms of screening adults without signs or symptoms of glaucoma
Glaucoma
Current Use of Hormonal Contraceptives May Up Glaucoma Risk
Authors say risk for glaucoma is low and should not discourage use of hormonal contraceptives
Genetic Predisposition + High Caffeine Intake Ups Risk of Increased Intraocular Pressure
High caffeine intake not associated with increased risk for higher IOP or glaucoma, overall; among those with genetic risk, caffeine consumption increases risk of glaucoma
One-Quarter in Ocular HTN Treatment Study Developed Visual Field Loss
20-year cumulative incidence of primary open angle glaucoma was 45.6 percent after adjustment for exposure time
Generic Version of Azopt Now Available
Brinzolamide ophthalmic suspension 1% is indicated for elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Study Examines Patient Perceptions of Marijuana as Glaucoma Treatment
Research shows patients with glaucoma are likely to encounter conflicting opinions on marijuana’s role in glaucoma therapy, especially from dispensaries.
Study: Beta-Blockers May Increase Risk of Glaucoma in Some Patients
Researchers investigated an association between blood pressure medications and glaucoma.
Anti-VEGF Injections May Reduce Glaucoma Burden for Some
Study shows reductions in intraocular pressures and antiglaucoma medication use.
Evaluating Reluctance to Embrace Selective Laser Trabeculoplasty as Front-Line Therapy
A growing body of research shows SLT for first-line glaucoma therapy works as well as drops — so why aren’t clinician’s embracing it?
New Drug Product: Durysta
This slideshow shows drug information for Durysta. Click here for the complete Durysta monograph.
